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Acute Responses of Cytokines and Adipokines to Aerobic Exercise in Women with Relapsing vs. Remitting 
Multiple Sclerosis 
 
ABSTRACT 
Objective: To examine the acute effect of exercise on cytokines and adipokines during relapse and the remitting 
phase of multiple sclerosis (MS). 
Methods: Thirty women with MS in the relapsing or remitting phase were matched with fifteen healthy controls. 
Participants performed a single-bout of aerobic exercise at 60-70% maximal heart rate. Furthermore, five women in 
the relapsing phase were enrolled (control relapse) and did not receive any intervention. Blood samples were taken 
before, immediately after, 1-hour and 6-hours after the exercise.  
Results: Levels of IL-10 and TNF-α in response to exercise were similar in healthy and MS remitting subjects. 
Compared to baseline, TNF-α levels in relapsing subjects were significantly decreased immediately after exercise. 
Immediately following exercise, leptin levels significantly decreased in relapsing subjects. Adiponectin and IL-6 
showed no significant difference between groups.  
Conclusion: After relapse, exercise does not induce inflammatory cytokine response and temporarily improves both 
cytokine and adipokine balance. 
 
Keywords: Multiple sclerosis; Cytokines; Inflammation; Adipokines; Aerobic interval exercise 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
1. Introduction 
 
Multiple sclerosis (MS) is an autoimmune disease characterized by inflammation, demyelination and 
axonal loss of the central nervous system (CNS) [1-5]. MS can be subdivided into four clinical courses: relapsing- 
remitting (RRMS), primary progressive (PPMS), secondary progressive (SPMS), and progressive relapsing (PRMS) 
[6]. RRMS is the most common form of MS [7]. RRMS is characterized by relapsing phases in which new or 
exacerbating symptoms appear [4].  The underlying pathways that activating this relapsing phase are unclear [2, 3, 
8]. Cytokines and their related pathways are considered to be major regulators of the immune system [9, 10] which 
may be important in the evolution of MS lesions and disease activity [9]. During relapse, some important 
abnormalities and imbalances occur [2, 3, 8]; therefore, an accurate examination of the effects of environmental 
stressors such as acute bouts of exercise is essential. 
Although, the causes of MS are still unclear, T helper (Th) and T regulatory (Treg) lymphocytes have been 
suggested to play a major role in the development of the disease [11]. In fact, Th lymphocyte cells can produce and 
secrete pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-6 [12] and furthermore, 
some anti- inflammatory cytokines such as IL-10. The latter cause down-regulation of inflammatory Th cell 
function, which in turn leads to anti-inflammatory triggers [12]. The evidence suggests a key role of acute 
dysregulation of the cytokine balance on acute inflammatory lesions in the relapsing phases of MS accompanied by 
an increase in the production of pro-inflammatory cytokines that results in acute inflammation [12, 13]. 
In the last decade, extensive attention has been paid to the close association between adipose tissue and 
inflammation [14, 15]. For instance, it has been reported that leptin is involved in the neurodegenerative and 
inflammatory environment that sustains MS [16]. In this regard, experimental evidence confirms the well-known 
impact of leptin and adiponectin on immunological function [17]. Previous studies in this field have verified the 
roles of leptin and adiponectin in the maintenance of energy balance, food intake and body mass [14, 17]. Moreover, 
the important roles of leptin on immunological function through regulation of Th balance are well known [3]. In 
addition, there is strong evidence that indicates that leptin levels increase during relapse and can also affect the 
response pattern of cytokines [16, 17]. Therefore, the acute response of adipokines, such as leptin, to exercise is an 
important issue, which has been neglected in previous studies in MS patients. 
Exercise training has a more robust stress paradigm compared to psychological stress [18, 19]. For 
instance, exercise is known to induce anti-inflammatory mediators such as IL-10 [20]. The cytokine response to 
exercise is well documented in a normal healthy population and is dependent on the mode, intensity and duration of 
exercise [21]. However, considerably less is known regarding these responses in MS, whilst this is critical to 
understanding the impact of exercise in MS patients. The importance of acute exercise is that it serves as a model for 
understanding exercise as a stressor that might result in long-term adaptations in a response to a single bout of 
exercise. That is, the repeated exposure to the acute stimulus might change the acute response over time as an 
adaptation and chronic alteration. Heesen et al. [22] reported a blunted cytokine response of TNF-α and IL-10 in 
sedentary MS subjects compared to trained MS subjects following a single 30 minute bout of exercise, when 
compared to trained MS subjects [22]. In another longitudinal study, Schulz et al. [23] indicated that chronic 
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exercise training may improve quality of life and cognitive function in persons with MS, without significant 
modulations in IL-6 or soluble interleukin-6 receptor (sIL-6) activity [23]. However, further investigation is 
warranted to determine how these responses may vary with an increased exercise stress and a wider variety of stress 
biomarkers. Most treatments and medications prescribed at this time to reduce inflammation in the MS relapse 
course, include optimization of the pro- and anti-inflammatory cytokines balance [8, 24]. Though, exercise was also 
shown to affect this course [22, 23]. Therefore, it should be examined how exercise can affect cytokines balance 
during relapse, and whether exercise can be beneficial or should be avoided during relapse. However, acute 
responses of adipokines to exercise have not been described previously in the relapsing and remitting phase in MS 
subjects, neglecting of the role of acute exercise on cytokines during relapses in MS. Nevertheless, we believe that 
the disease course may interact with cytokines and adipokines responses to an acute bout of exercise. Therefore in 
order to analyze the impact of exercise on immune status in MS, the present study aimed to investigate the response 
of various cytokines (TNF-α, IL-10, IL-6) and adipokines (adiponectin and leptin) to an acute bout of exercise in the 
relapsing and remitting phase of MS, compared to healthy controls. 
 
2. Materials and methods 
 
2.1. Subjects 
 
As the effect size for responses of cytokines and adipokines to acute bouts of exercise in MS has not been 
calculated before, and according to previous studies, Cohens’ classification (f=0.3) was used for power analysis 
which indicates a small to moderate effect. Moreover, a significance level of 0.05 and statistical test-power of 0.8 
was used. The correlation of time points was estimated at r=0.5. The subsequent calculation indicated a total sample 
size of 28 (G*power 3.0.10 software, Germany). Factoring in a drop-out of 15%, the minimum total sample size 
required was 33 participants. The current study recruited thirty five participants with MS, including fifteen women 
during remitting and twenty women during relapse with RRMS (mean EDSS score = 2.11±0.76), according to the 
McDonald 2010 criteria [25] from the MS society center of Khuzestan, Iran under the observation of a neurologist. 
A further fifteen healthy women (healthy control) ranging from 20-35 years old were recruited. Healthy control 
subjects had neither laboratory nor clinical symptoms of infectious, autoimmune or inflammatory diseases. The 
objectives, risks and benefits of the study were explained to all enrolled members, followed by collection of written 
informed consent. This study was approved by the Ethics committee of Jundishapur University of Medical Sciences, 
Ahvaz, Iran (registration number: IRCT2016031427047N1). 
 
2.2. Study design and procedure 
 
 At baseline, persons with RRMS (n = 35) were divided into three groups: a relapsing exercise group (n = 
15), a remitting exercise group (n = 15) and a relapsing control group (n = 5). Aerobic capacity (maximal oxygen 
uptake, VO2max) was determined [26] four days before initiation of the exercise sessions. After a 10-hour overnight 
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fasting period, subjects arrived at the ergometry laboratory, and consumed the same standardized breakfast under the 
researchers’ supervision 60 minutes prior to the beginning of the exercise session.  Anthropometric measures and 
physical activity (PA) levels were assessed. After 60 minutes of seated inactive rest, subjects performed an exercise 
bout consisting of upper and lower limb cycling performed at an intensity of 60-70% of maximum heart rate (HRmax) 
determined from the maximal exercise test. Blood samples were collected at four different time points: before 
initiation of the exercise, immediately after, 1-hour after and 6-hours after completion of the exercise (Figure 1). 
Relapse definition was based on the 2010 revisions of McDonald criteria as “patient-reported symptoms or 
objectively observed signs typical of an acute inflammatory demyelinating event in the CNS, current or historical, 
with duration of at least 24 hours, in the absence of fever or infection” [25]. 
 
2.3. Physical activity 
 
PA was monitored four days prior to the exercise sessions using the Baecke physical activity questionnaire 
[27]. The Baecke questionnaire includes a total of three domains scored on a Likert scale. The average score for the 
three domains was the overall activity score, with a score of five indicating the highest possible physical activity 
[27]. 
 
2.4. Anthropometric measurements 
 
Based on each patient’s body mass (kg) and squared height (cm2), body mass index (BMI) was calculated. 
Also, skinfold thickness was measured at thigh, suprailium and triceps sites via Harpenden calipers (®) according to 
the instructions previously highlighted [28]. Body density subsequently was estimated by a three-site skinfold 
thickness equation [28], after which the Siri equation was used to estimate body fat percentage (BFP) [29].  
 
2.5. Aerobic capacity 
 
In order to determine aerobic capacity (VO2max), subjects cycled for four min without resistance on a cycle 
ergometer. Work rate was subsequently increased by 15 watts (w) per minute until exhaustion, while pedaling rate 
was maintained at a constant 60 revolutions per minute (rpm). Heart rate was monitored throughout the test in order 
to provide a maximal heart rate value, which was used to determine the intensity of exercise in the subsequent 
exercise sessions. Finally, maximal workload (watt), age (years) and weight (kg) of subjects were used to determine 
their VO2max (ml.kg.min-1) [26].  
 
2.6. Exercise bout 
 
Subjects were asked to refrain from strenuous exercise and physical activity at least 4 days prior to the 
exercise session. Exercise consisted of four sets of 5 minute intervals of upper body cycling and four sets of lower 
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body cycling interspersed with 2 minutes of passive rest between each interval. The intensity of each bout of interval 
exercise was adjusted to achieve an intensity of 60-70% HRmax. It should be noted that, after completing the 
exercise, subjects remained seated passively for six hours. Furthermore, in the relapsing group exercise was 
performed 2 weeks after the onset of an acute relapse. Temperature and humidity were controlled during each trial at 
an average of 21.2±1.07 C and 37.24±3.41%, respectively. 
 
2.7. Blood sampling and assays 
 
Venous blood samples were collected at 4 different time points and centrifuged immediately after 
collection; the resulting serum was aliquoted and stored at -70C.  Serum high density lipoprotein (LDL), high 
density lipoprotein (HDL) and triacylglycerol (TG) were measured using photometric method by Pars Azmoon kits. 
Cytokine concentrations were assessed via enzyme linked immunoassay ELISA kits and were conducted according 
to the manufacturer’s instructions. Leptin and adiponectin levels were obtained using R&D Systems kit 
(Minneapolis, USA) and BioVendor (Brno, Czech Republic), respectively. TNF-α and IL-10 levels were measured 
using IBL International GMBH kit (Hamburg, Germany). Also, IL-6 levels were measured using an R&D system 
kit. The intra and inter assay coefficient of variation (CV) for the performed samples was <7%. 
 
2.8. Statistical analysis 
 
Statistical analyses were performed by SPSS Statistics (IBM SPSS Statistics, version 21, Armonk, NY). 
Data were presented as means and standard deviation (mean±SD). Group differences at baseline were evaluated 
using one-way analysis of variance (ANOVA) with groups (relapse vs. control relapse vs. remitting vs. healthy 
controls) as the between-subjects factor. Post-hoc (Bonferroni-adjusted) tests were performed where appropriate. 
Repeated measures ANOVA were applied with regard to ‘group’ as the between-subjects factor (relapse vs. control 
relapse vs. remitting vs. healthy controls) and ‘time’ as the within subjects factor (baseline vs. immediately after vs. 
1-hour after vs. 6-hour after). Post-hoc (Bonferroni-adjusted) tests were performed in case of a significant 
time*group interaction. An alpha level of 0.05 was considered significant. 
 
3. Results 
 
3.1. Demographic data and baseline cytokines 
 
No differences were found between groups for age, weight and BMI (p >0.05). Mean disease duration in 
the MS groups was 3.04±0.94 years. Mean EDSS score of all RRMS was 2.11±0.76, with scores of 2.41±0.83 and 
1.82±0.65 for the relapsing and remitting groups, respectively. No significant differences in disease duration were 
found between the MS groups (all values p >0.05). 
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At baseline, VO2max and PA were significantly higher in the HC than the MS group (p <0.05, Table 1). 
Between MS groups, VO2max in the MS remitting group was significantly higher than the relapse group (p=0.003). 
No differences in PA were observed between MS groups (p =0.174). Significant baseline differences in cytokine 
levels between groups (all values p <0.05) were observed. Leptin levels were higher in the relapsing group when 
compared to the remitting (p=0.001) and control (p=0.001) groups. The remitting group showed higher levels of 
leptin than the control group (p=0.033). IL-10, IL-6 and adiponectin levels were similar between groups (P>0.05). 
Significant differences in basal TNF-α levels were present between groups (P=0.007). Subsequently, Bonferroni 
tests revealed significant differences between the relapsing group and healthy subjects (p=0.0.26) as well as between 
the remitting group and healthy subjects (p=0.024) while the MS groups were not significantly different (p=0.213) 
(Figure 2). Finally, significant baseline differences in TG levels between groups (p <0.05) were observed, with 
higher TG levels in the relapsing groups compared to remitting and control groups (Table 2). 
 
3.2. Cytokine and lipid profile responses to exercise 
 
Significant time effects were observed for leptin (p=0.001), IL-6 (0.004) and TNF-α (0.021). However, for 
leptin and TNF-α, a post hoc test indicated a significant decrease (p=0.002) and increase (p=0.013) 1-hour after 
completion of the exercise bout, respectively. With the exception of adiponectin (p=0.09), a significant time*group 
interaction was observed for all cytokines (p <0.05) (Figure 3). Moreover, TG indicated a significant time*group 
interaction (P=0.004). TG (p=0.031) and heart rate (p=0.001) showed a time effect. 
Immediately following exercise, TNF-α concentrations significantly decreased in relapsing (p=0.001) 
subjects but significantly increased in remitting (p=0.013) subjects. A marked increase was observed 1-hour after 
exercise in TNF-α in relapsing subjects compared to immediately after exercise (p=0.006), whilst no change was 
observed in the control relapsing group (p >0.05). A significant decrease in IL-10 was observed immediately after 
exercise in relapsing subjects (p=0.023). In remitting subjects, a significant increase was observed 1-hour after 
exercise compared to baseline (p=0.010). All three exercise groups showed similar IL-6 responses increasing 
immediately after exercise (p <0.01) with no significant change in other time points (p >0.05). Leptin concentration 
was decreased significantly in the relapse group (p=0.001) immediately after exercise, however no change was 
observed in other groups (p >0.05). All groups, with the exception of the control relapsing group, showed a 
significant decrease 1-hour after exercise in leptin concentrations (p <0.02), while the degree of change in the 
relapsing group was significantly higher compared to other groups. Finally, leptin levels of MS subjects who 
performed exercise remained significantly lower compared to baseline and 6-hours following exercise (p=0.019). 
 
4. Discussion 
 
In the present study, we investigated cytokine responses to a single exercise-bout in both the relapsing and 
remitting phases of MS. Responses of IL-10 and TNF-α levels to an acute bout of exercise were comparable in HC 
and MS remitting subjects. Subjects in the relapsing phase of MS showed a significant decrease and increase in 
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TNF-α levels respectively compared to baseline, immediately and 1-hour after exercise. Moreover, immediately 
after exercise, leptin significantly decreased in the MS relapsing subjects. Finally, there were no significant 
differences in IL-6 or adiponectin responses to exercise between groups. 
The underlying pathogenesis of relapses depends on the presence of new inflammatory plaques that are 
caused by activation of the immune system [2, 12]. It is not clear which inflammatory pathways are associated with 
relapses and this has a pivotal role in determining a more stimulated disease activity [2]. Several cytokines such as 
TNF-α, IL-10, IL-6, INF-y, and leptin, were associated with a more active phase of the disease [12, 17]. In this 
regard, the results of the present study indicate that leptin was higher in relapsing vs. remitting subjects accompanied 
by significantly higher TG in the relapsing groups. Also, MS groups indicated higher levels of leptin compared to 
the healthy control group. 
The presence of leptin is essential for the induction and progression of several experimental models of 
autoimmune diseases [30]. While most pro-inflammatory cytokines such as TNF-α only increase during relapse 
[31], it has been revealed that circulating leptin increases prior to the relapsing phase in MS followed by a marked 
reduction during the relapse. These findings suggest that variations in leptin anticipate cytokine pattern changes 
[16]. For these reasons, it is commonly agreed that leptin is a crucial factor in the pathogenesis of some immune-
mediated disorders and inflammatory responses [16, 17]. 
It has also been suggested that the release of cytokines during exercise may contribute to the maintenance 
of immune homeostasis [31]. On the other hand, exercise is concomitant with a mild physical stressor and exhibits 
an array of modular effects on the immune system [23]. Consequently, cytokine responses to exercise could 
contribute to neuroprotection [22, 31]. In addition, investigating the immunological response to exercise in people 
with MS may provide important information regarding the impact of acute exercise on how people with MS respond 
to physical stress in general. 
Le Page et al. (1994) reported that, during the inflammatory phase of EAE, exercise did not exacerbate the 
disease course [32]. Limited research has addressed the acute effect of exercise on cytokine responses in MS 
subjects. Hessen et al. [22] examined cytokine responses to standardized physical stress (60% VO2 max for 30 min) 
in MS, showing that such stress did not induce a pro-inflammatory immune deviation [22]. In another study, 
Kjolhede et al. [30] reported that cytokine responses to resistance exercise were without significant change in IL-10 
and TNF-a. However, other cytokines have been found to be similar in trained and untrained MS subjects [31]. In all 
of these studies MS patients were recruited in the remitting phase of the disease. In the present study, however, in 
order to fully comprehend cytokine responses, we also included subjects in the relapsing phase of the disease. 
Finally, we observed almost identical response of cytokines to acute bouts of exercise in MS remitting and control 
subjects. Relapsing subjects showed different cytokine responses to exercise, specifically for leptin and TNF-α. For 
leptin, we clearly showed a marked tendency for reduction during relapses. However, leptin concentrations were still 
higher in the relapsing group compared to other subjects who performed the exercise. 
The decreased response level of serum leptin to physical stress, such as exercise, can result in 
immunosuppression as lower levels of leptin are related to Th1 cell responses that can decrease and improve Th2 
cell function [3, 17]. In fact, experimental evidence indicates that leptin concentrations are associated with 
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inflammatory processes and directly stimulate the production of inflammatory cytokines such as TNF-α and IL-6 
[14, 17]. Therefore, the reduced leptin levels in response to exercise in the relapsing group can be considered as an 
anti-inflammatory effect of exercise. However, more extensive investigations are required to ascertain the likelihood 
of this possibility. The obtained results indicate that TNF-α levels were reduced immediately after exercise in the 
relapsing group. However, 1-hour after exercise TNF-α tended to increase significantly in all groups. For IL-10, a 
significant increase was observed immediately after exercise in control subjects only. However, 1-hour after 
exercise the remitting group experienced an increase compared to baseline. Finally, a significant increase was 
demonstrated for IL-6 in all exercise groups. 
Given the complex function of both TNF-α and IL-6 on inflammatory processes, the present findings are 
difficult to interpret comprehensively. TNF-α possesses mutual functions, that are related to different receptors 
called p55 and p57 [33]. The majority of inflammatory responses of TNF-α are attributed to p55 while p75 mediates 
cell growth and proliferation [20, 33]. Therefore, recent studies have speculated that elevation of TNF-α levels may 
have either detrimental or beneficial effects on MS subjects [34]. On the other hand, the immunoregulatory 
properties of IL-10 inhibit the synthesis of many Th1-related cytokines (TNF-α, IL-1, IL-6). Therefore, it seems that 
the presence of IL-10 appears to be beneficial in MS subjects. Also, the lower levels of IL-10 in the relapsing group 
in response to exercise might be a result of an increase in pro-inflammatory cytokines at baseline which could be 
harmful in MS patients. The results of the present study indicate no changes in IL-10 in the relapsing group, which 
can be explained by lower levels of VO2max at baseline, as the IL-10 response to exercise depends to some extent on 
fitness level [35]. Furthermore, at baseline, a modest positive correlation was observed between IL-10 levels and 
VO2max in the relapsing group and healthy subjects. Interpretation of the cytokine responses suggests a regulative 
effect of exercise on cytokine balance without inducing inflammatory patterns. Finally, VO2max and PA differences 
between groups may, in part, explain the observed differences between cytokine responses which are not related to 
the applied protocols or disease course. 
In the present study cytokine measurements were only performed in blood samples. Further biochemical 
analysis in other areas, such as the cerebrospinal fluid, might produce different results. Furthermore, we chose to 
examine the impact of aerobic interval exercise. This choice was motivated by the fact that interval exercise may 
induce lower increases in body temperature due to the inclusion of rest and active periods. However, various 
characteristics of other types of exercise might influence the differences in cytokine responses. 
These findings reveal that responses of MS subjects to exercise can be similar to that of healthy controls. It 
should be noted that the balance of the Th1/ Th2 cytokines is less impaired in the benign phase of MS [18]. 
Furthermore, it seems possible that subjects with higher disability (EDSS>5) might respond differently to the 
exercise task. 
Several studies have suggested that cytokine responses can occur hours after an exercise bout [22]. 
Therefore, sampling time represents another limitation of our study and gives rise to the need for further research in 
order to support these results regarding cytokine responses to exercise. Finally, although pharmacological treatment, 
such as corticosteroids, can influence cytokine patterns, Kraszula et al. [17] reported higher levels of leptin after 2 
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weeks of corticosteroid treatment in relapsing subjects [17]. In order to counter this, the present study included a 
control relapsing group to minimize and eliminate the effect of any pharmacological treatment. 
 
6. Conclusions 
 
We showed that relapsing phase of MS is associated with a cytokine imbalance. Importantly, acute exercise 
does not seem to influence the inflammatory response of the cytokines measured. Nevertheless, the reduction of 
leptin and TNF-α levels in response to exercise in relapsing groups can be considered as an anti-inflammatory effect 
of exercise training. Therefore, exercise may temporarily improve the cytokine balance in MS subjects, particularly 
those in the relapse phase. Given that one of the targets of treatment and medication in relapse is the reduction of 
inflammation, acute exercise can also be considered as an effective strategy. Although our preliminary study showed 
that exercise, from a cytokine and adipokine perspective, could represent valid therapy in the relapsing phase of MS, 
further studies need to fully determine the potential of exercise as a complementary therapy during relapse. Finally, 
it can be argued that exercise is safe in relation to cytokine and adipokine concentrations following relapse in 
RRMS. 
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Table 1 
Baseline characteristics of the relapsing, remitting MS and healthy control group  
 Age 
(years) 
Weight 
(kg) 
BMI 
(kg/cm2) 
BPF 
(%) 
VO2max 
(ml/kg.min) 
PA 
(score) 
Relapsing MS 28.23±3.65 68.51±4.28 23.16±1.20 33.24±5.47 19.19±6.37 2.21±0.87 
Remitting MS 29.16±4.81 64.20±5.11 22.75±1.07 31.65±3.87 23.21±2.87# 2.19±0.36 
Healthy control  28.10±6.11 62.38±3.91 22.37±1.67 33.79±6.37 29.37±3.17* 3.07±0.41* 
Data are presented as Mean±SD and represent baseline differences of BMI, BFP, VO2max and physical activity in 
relapsing (n=20), remitting (n=15) MS and healthy controls (n=15). * p<0.05 between control group and MS groups. 
# 
 p<0.05 between MS remitting and relapsing group; BMI: body mass index; BFP; body fat percent; VO2max; 
maximum rate of oxygen consumption; PA: physical activity; kg/cm2: kilogram/centimeter; ml/kg.min: 
milliliter/kilogram.minute. 
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Table 2 
Heart rate and lipid profile response to exercise in relapse (n=15), control relapse (n=5), remitting (n=15) and 
control group (n=15). 
 
Baseline Immediately after 
exercise 
1-hour after 
exercise 
6-hour after 
exercise 
Heart 
rate 
(bpm) 
Relapsing MS  75.16±4.61 129.16±7.14 86.12±4.61 74.15±6.05 
Control relapsing MS  77.11±6.12 75.18±9.07 75.94±6.05 78.12±6.10 
Remitting MS 73.16±4.81 127.20±4.18 81.11±7.34 76.61±4.39 
Healthy control  68.67±6.57 130.19±6.11 70.28±2.77 69.57±2.33 
TG 
(mg/dL) 
Relapsing MS  132.27 ± 
11.11#ª 
114.16 ± 12.16*# 118.24 ± 16.21 128.11 ± 
18.24# 
Control relapsing MS  129.45 ± 
18.67#ª 
126.72 ± 20.16#ª 120.14 ± 19.60 121.12 ± 7.29 
 Remitting MS 116.19 ± 15.74 110.12 ± 13.94 112.87 ± 20.12 117.25 ± 14.11 
Healthy control  105.16 ± 9.94 99.14 ± 14.16 104.64 ± 10.64 103.27 ± 15.61 
HDL 
(mg/dL) 
Relapsing MS  49.19±4.88 51.12±8.07 51.19±9.11 48.16±4.12 
Control relapsing MS  47.28±6.16 48.11±6.74 44.22±7.65 47.19±6.54 
 Remitting MS 54.20±3.16 53.78±6.91 52.17±4.09 53.26±6.61 
Healthy control  51.44±4.74 57.26±5.17 54.19±3.45 52.16±6.90 
LDL 
(mg/dL) 
Relapsing MS  114.64 ± 7.87 113.94 ± 10.12 114.42 ± 14.51 110.09 ± 6.67 
Control relapsing MS  114.54 ± 12.93 112.16 ± 9.61 115.94 ± 9.62 112.66 ± 11.25 
 Remitting MS 108.57 ± 12.06 109.71 ± 15.12 106.16 ± 10.09 105.28 ± 16.21 
Healthy control  108.84 ± 6.64 101.12 ± 9.78 107.81 ± 11.65 110.29 ± 14.36 
Data are given as Mean±SD. TG indicated significant time*group interacts (P <0.05). TG and Heart rate showed a 
time effect (P <0.05). * refers to the significant differences in comparison to baseline (p<0.05). # refers to the 
significant differences in comparison to the control group (p<0.05). ª refers to the significant differences in 
comparison to the Remitting group (p<0.05). TG: Triglyceride; HDL: High-density lipoproteins; LDL: Low-density 
lipoproteins. 
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Fig. 1. Timeline of exercise stress session; the exercise consisted of four sets of 5 minutes intervals of upper body 
cycling and four sets of lower body cycling interspersed with 2 minutes of passive rest between each interval. 
Subjects were asked to start cycling after sitting 5-min on the ergometer. Lower and upper limb cycling was 
considered as exercise stress which was set using percentage of HRmax. The intensity of each bout of interval 
exercise was adjusted to achieve an intensity of 60-70% HRmax. 
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Fig. 2. Baseline differences in cytokine parameters between in relapse (n=20), remitting (n=15) and control group 
(n=15). Data are given as Mean±SD. * refers to the significant differences in comparison to the other groups; # refers 
to the significant differences in comparison to the control group; IL-10: Interleukin 10; TNF-α: tumor necrosis factor 
alpha; IL-6: Interleukin 6. 
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Fig. 3. Leptin (a), Adiponectin (b), TNF-α (c), IL-10 (d) and IL-6 (e) response to exercise in relapse (n=15), control 
relapse (n=5), remitting (n=15) and control group (n=15). Data are given as Mean±SD. * refers to the significant 
differences in comparison to baseline. # refers to the significant differences in comparison to the control group. † 
refers to the significant differences in comparison to the control relapse group. IL-10: Interleukin 10; TNF-α: tumor 
necrosis factor alpha; IL-6: Interleukin 6. Pre: baseline; Post-1: immediately after exercise; Post-2: 1-hour after 
exercise; Post-3: 6-hour after exercise. 
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Exercise does not influence the inflammatory response of the cytokine profile. 
Exercise temporarily improves cytokine and adipokine balance in the relapsing phase of multiple sclerosis. 
Exercise successfully influences leptin in relapses of multiple sclerosis. 
Exercise seems safe, tolerable and feasible following relapse in multiple sclerosis patients. 
 
